Gelatin–thrombin-based Hemostatic Sealant for Intraoperative Bleeding in Vascular Surgery

[1]  Howard S. An,et al.  A Multicenter, Prospective, Randomized Trial Evaluating a New Hemostatic Agent for Spinal Surgery , 2001, Spine.

[2]  M. Oz,et al.  Controlled clinical trial of a novel hemostatic agent in cardiac surgery , 2000 .

[3]  D. Gillespie,et al.  Hemostatic efficacy of fibrin sealant (human) on expanded poly-tetrafluoroethylene carotid patch angioplasty: a randomized clinical trial. , 1999, Journal of vascular surgery.

[4]  J. Zwischenberger,et al.  Comparison of two topical collagen-based hemostatic sponges during cardiothoracic procedures. , 1999, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[5]  R. Christie,et al.  Postoperative bleeding induced by topical bovine thrombin: report of two cases. , 1997, Surgery.

[6]  M. Tarantino,et al.  Modulation of an acquired coagulation factor V inhibitor with intravenous immune globulin. , 1997, Journal of pediatric hematology/oncology.

[7]  J. Weisel,et al.  Simultaneous Occurrence of Human Antibodies Directed against Fibrinogen, Thrombin, and Factor V Following Exposure to Bovine Thrombin: Effects on Blood Coagulation, Protein C Activation and Platelet Function , 1997, Thrombosis and Haemostasis.

[8]  N. M. Edwards,et al.  Immunologic Assessment of Patients Treated with Bovine Fibrin as a Hemostatic Agent , 1996, Thrombosis and Haemostasis.

[9]  W. Wagner,et al.  Comparative in vitro analysis of topical hemostatic agents. , 1996, The Journal of surgical research.

[10]  R. Pierce,et al.  Brief report: fatal hemorrhage in a patient with an acquired inhibitor of human thrombin. , 1995, The New England journal of medicine.

[11]  D. Cosgrove,et al.  Randomized Clinical Trial of Fibrin Sealant in Cardiac Surgery Patients Undergoing Resternotomy or Reoperation: A Multicenter Study , 1995 .

[12]  S. Israels,et al.  Development of Antibodies to Bovine and Human Factor V in Two Children After Exposure to Topical Bovine Thrombin , 1994, American Journal Of Pediatric Hematology/Oncology.

[13]  T. Ortel,et al.  Topical thrombin and acquired coagulation factor inhibitors: Clinical spectrum and laboratory diagnosis , 1994, American journal of hematology.

[14]  W. Muntean,et al.  Inhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a two‐year‐old child , 1994, Acta paediatrica.

[15]  A. Tobler,et al.  Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V , 1993, British journal of haematology.

[16]  J. Amiral,et al.  Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors. , 1993, Journal of Thoracic and Cardiovascular Surgery.

[17]  R. E. Clark,et al.  Redo cardiac surgery: late bleeding complications from topical thrombin-induced factor V deficiency. , 1993, The Journal of thoracic and cardiovascular surgery.

[18]  S. Rapaport,et al.  Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin. , 1992, American journal of clinical pathology.

[19]  J. Zehnder,et al.  Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin. , 1990, Blood.

[20]  D. Cosgrove,et al.  Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. , 1989, The Journal of thoracic and cardiovascular surgery.